178 related articles for article (PubMed ID: 16842880)
1. Copper-topotecan complexation mediates drug accumulation into liposomes.
Taggar AS; Alnajim J; Anantha M; Thomas A; Webb M; Ramsay E; Bally MB
J Control Release; 2006 Aug; 114(1):78-88. PubMed ID: 16842880
[TBL] [Abstract][Full Text] [Related]
2. Formation of transition metal-doxorubicin complexes inside liposomes.
Abraham SA; Edwards K; Karlsson G; MacIntosh S; Mayer LD; McKenzie C; Bally MB
Biochim Biophys Acta; 2002 Sep; 1565(1):41-54. PubMed ID: 12225851
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes.
Abraham SA; Edwards K; Karlsson G; Hudon N; Mayer LD; Bally MB
J Control Release; 2004 May; 96(3):449-61. PubMed ID: 15120901
[TBL] [Abstract][Full Text] [Related]
4. Transition metal-mediated liposomal encapsulation of irinotecan (CPT-11) stabilizes the drug in the therapeutically active lactone conformation.
Ramsay E; Alnajim J; Anantha M; Taggar A; Thomas A; Edwards K; Karlsson G; Webb M; Bally M
Pharm Res; 2006 Dec; 23(12):2799-808. PubMed ID: 17063397
[TBL] [Abstract][Full Text] [Related]
5. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese.
Chiu GN; Abraham SA; Ickenstein LM; Ng R; Karlsson G; Edwards K; Wasan EK; Bally MB
J Control Release; 2005 May; 104(2):271-88. PubMed ID: 15907579
[TBL] [Abstract][Full Text] [Related]
7. The role of the transition metal copper and the ionophore A23187 in the development of Irinophore C™.
Patankar N; Anantha M; Ramsay E; Waterhouse D; Bally M
Pharm Res; 2011 Apr; 28(4):848-57. PubMed ID: 21181548
[TBL] [Abstract][Full Text] [Related]
8. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
[TBL] [Abstract][Full Text] [Related]
9. Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancer.
Patankar NA; Waterhouse D; Strutt D; Anantha M; Bally MB
Invest New Drugs; 2013 Feb; 31(1):46-58. PubMed ID: 22615060
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the physicochemical state of interior agents to prepare controlled release liposomes.
Wang N; Wang T; Li T; Deng Y
Colloids Surf B Biointerfaces; 2009 Mar; 69(2):232-8. PubMed ID: 19131224
[TBL] [Abstract][Full Text] [Related]
11. A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention.
Ramsay E; Alnajim J; Anantha M; Zastre J; Yan H; Webb M; Waterhouse D; Bally M
Eur J Pharm Biopharm; 2008 Mar; 68(3):607-17. PubMed ID: 17904831
[TBL] [Abstract][Full Text] [Related]
12. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
[TBL] [Abstract][Full Text] [Related]
13. Optimization of liposomal topotecan for use in treating neuroblastoma.
Chernov L; Deyell RJ; Anantha M; Dos Santos N; Gilabert-Oriol R; Bally MB
Cancer Med; 2017 Jun; 6(6):1240-1254. PubMed ID: 28544814
[TBL] [Abstract][Full Text] [Related]
14. Loading of doxorubicin into liposomes by forming Mn2+-drug complexes.
Cheung BC; Sun TH; Leenhouts JM; Cullis PR
Biochim Biophys Acta; 1998 Nov; 1414(1-2):205-16. PubMed ID: 9804955
[TBL] [Abstract][Full Text] [Related]
15. Freeze drying of double emulsions to prepare topotecan-entrapping liposomes featuring controlled release.
Wang T; Wang N; Li T; Deng Y
Drug Dev Ind Pharm; 2008 Apr; 34(4):427-33. PubMed ID: 18401785
[TBL] [Abstract][Full Text] [Related]
16. pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol.
Dos Santos N; Cox KA; McKenzie CA; van Baarda F; Gallagher RC; Karlsson G; Edwards K; Mayer LD; Allen C; Bally MB
Biochim Biophys Acta; 2004 Feb; 1661(1):47-60. PubMed ID: 14967474
[TBL] [Abstract][Full Text] [Related]
17. Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes.
Dos Santos N; Mayer LD; Abraham SA; Gallagher RC; Cox KA; Tardi PG; Bally MB
Biochim Biophys Acta; 2002 Apr; 1561(2):188-201. PubMed ID: 11997119
[TBL] [Abstract][Full Text] [Related]
18. The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.
Fugit KD; Anderson BD
J Control Release; 2014 Jan; 174():88-97. PubMed ID: 24231406
[TBL] [Abstract][Full Text] [Related]
19. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of topotecan in low pH liposomes composed of distearoylphosphatidylcholine.
Burke TG; Gao X
J Pharm Sci; 1994 Jul; 83(7):967-9. PubMed ID: 7965676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
